$Aerie医药(AERI)$ The purchase price of $15.25 per share represents a premium of 37% to Aerie’s last closing price and represents an equity value of approximately $770 million. The transaction was approved by the board of directors of each company.
发布于: | 雪球 | 转发:0 | 回复:0 | 喜欢:0 |
$Aerie医药(AERI)$ The purchase price of $15.25 per share represents a premium of 37% to Aerie’s last closing price and represents an equity value of approximately $770 million. The transaction was approved by the board of directors of each company.